Opportunity evaluation
Make evaluation evidence visible before the decision.
PartnerFlow helps teams evaluate life sciences opportunities through a shared process that connects criteria, evidence, stakeholder input, missing information, risks, recommendations, and governance actions to the opportunity being assessed.
Use repeatable evaluation criteria
Define the questions and dimensions that matter for the opportunity instead of relying on inconsistent documents or personal scoring methods.
- Scientific and clinical evidence
- Commercial and strategic fit
- Operational, legal, financial, and partnership considerations
Separate evidence from assertion
Link a recommendation to its supporting records and show where information is incomplete or disputed.
- Evidence-linked observations
- Visible assumptions and open questions
- Review history and accountability
Prepare a decision-ready view
Summarize the current recommendation, major risks, stakeholder coverage, supporting evidence, missing information, and required approvals.
- Clear decision status
- Reviewable rationale
- Defined next action
Questions and answers
Frequently asked questions
How should a biotech opportunity be evaluated?
A useful evaluation combines defined criteria with source evidence, multidisciplinary review, explicit assumptions, documented risks, a recommendation, and a governed decision. The exact criteria should reflect the asset, development stage, deal type, and company strategy.
What is a decision room?
A decision room is a focused view that assembles the evidence, evaluation results, risks, recommendations, missing information, stakeholders, tasks, and approvals required for a specific decision.
A connected decision process
Move the next partnership forward with clarity.
See how PartnerFlow can support your team’s partnering workflow.
Request a demo